Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.37 -0.03 (-7.50%)
At close: Oct 22, 2026 · 4:00 PM EDT

Citius Pharmaceuticals (CTXR) Gross Profit (2025 - 2026)

Updated

Citius Pharmaceuticals (CTXR) recorded Gross Profit of $1 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.1% from the prior quarter.

Analysis

Citius Pharmaceuticals (CTXR) Gross Profit (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Citius Pharmaceuticals 10.16 Mn -14.12 Mn 1.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Mn
Mar 31, 2026 1.34 Mn
Dec 31, 2025 3.15 Mn
API Access

Citius Pharmaceuticals Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CTXR&period=max&api_key=YOUR_API_KEY